CAS No. |
9025-82-5 |
|---|---|
中文名称 |
N6,N6-二甲基-5,6,7,8-四氢萘并[2,3-d]噻唑-2,6-二胺--N6,N6-二甲基-6,7-二氢-5H-茚并[5,6-d]噻唑-2,6-二胺--N7,N7-二甲基-5,6,7,8-四氢萘并[2,3-d]噻唑-2,7-二胺--N7,N7-二甲基-7,8-二氢-6H-茚并[4,5-d]噻唑-2,7-二胺--N7,N7-二甲基-7,8-二氢-6H-茚并[5,4-d]噻唑-2,7-二胺(1/1/1/1/1) |
英文名称 |
N6,N6-dimethyl-5,6,7,8-tetrahydronaphtho[2,3-d]thiazole-2,6-diamine--N6,N6-dimethyl-6,7-dihydro-5H-indeno[5,6-d]thiazole-2,6-diamine--N7,N7-dimethyl-5,6,7,8-tetrahydronaphtho[2,3-d]thiazole-2,7-diamine--N7,N7-dimethyl-7,8-dihydro-6H-indeno[4,5-d]thiazole-2,7-diamine--N7,N7-dimethyl-7,8-dihydro-6H-indeno[5,4-d]thiazole-2,7-diamine (1/1/1/1/1) |
别名 |
EC 3.1.4.1 TYPE IV;EC 3.1.4.1 TYPE V;EC 3.1.4.1 TYPE VI;EC 3.1.4.1;IUB: 3.1.4.1;5'-EXONUCLEASE;5'-EXONUCLEASE TYPE IV;5'-EXONUCLEASE TYPE V |
标准英文名 |
N6,N6-dimethyl-5,6,7,8-tetrahydronaphtho[2,3-d]thiazole-2,6-diamine--N6,N6-dimethyl-6,7-dihydro-5H-indeno[5,6-d]thiazole-2,6-diamine--N7,N7-dimethyl-5,6,7,8-tetrahydronaphtho[2,3-d]thiazole-2,7-diamine--N7,N7-dimethyl-7,8-dihydro-6H-indeno[4,5-d]thiazole-2,7-diamine--N7,N7-dimethyl-7,8-dihydro-6H-indeno[5,4-d]thiazole-2,7-diamine (1/1/1/1/1) |
分子式 |
C62H79N15S5 |
分子量 |
1194.75 |
精确分子量 |
1193.52 |
SMILES |
CN(C)C1CC2=C(C1)C1=C(C=C2)N=C(N)S1.CN(C)C1CC2=C(C1)C1=C(C=C2)SC(N)=N1.CN(C)C1CC2=CC3=C(C=C2C1)SC(N)=N3.CN(C)C1CCC2=CC3=C(C=C2C1)N=C(N)S3.CN(C)C1CCC2=CC3=C(C=C2C1)SC(N)=N3 |
标准SMILES |
CN(C)C1CC2=CC3N=C(N)SC=3C=C2C1.CN(C)C1CC2=CC3N=C(N)SC=3C=C2CC1.CN(C)C1CC2C=CC3N=C(N)SC=3C=2C1.CN(C)C1CC2C3N=C(N)SC=3C=CC=2C1.CN(C)C1CC2=CC3SC(N)=NC=3C=C2CC1 |
用途 |
Phosphodiesterase I has become an attractive therapeutic target in drug development, with applications in cardiovascular, reproductive, anti-inflammatory, and immunological fields, among others, involving various PDE isoenzymes. |
InChIKey |
WGMBBKSEXJMGFF-UHFFFAOYSA-N |
|
|
评论 |
|---|